bibliographicCitation |
Hendricksen K, van der Heijden AG, Cornel EB, Vergunst H, de Reijke TM, van Boven E, Smits GAHJ, Puri R, Gruijs S, Witjes JA. Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer. World Journal of Urology. 2009 Feb 13;27(3):337–42. doi: 10.1007/s00345-009-0382-4. |